IFIT2 and cancer: In another type of head and neck cancer (HNC), nasopharyngeal carcinoma, microarray data analysis indicated that the expression of IFIT2 is downregulated in chemoradiotherapy-resistant cancer cells compared to that of sensitive cells [64].